Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome

被引:192
作者
Lee, Abigail M.
Clear, Andrew J.
Calaminici, Maria
Davies, Andrew J.
Jordan, Suzanne
MacDougall, Finlay
Matthews, Janet
Norton, Andrew J.
Gribben, John G.
Lister, T. Andrew
Goff, Lindsey K.
机构
[1] St Bartholomews Hosp, Canc Res UK Med Oncol Unit, London, England
[2] St Bartholomews Hosp, Dept Histopathol, London, England
关键词
D O I
10.1200/JCO.2006.06.4642
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To examine the immune microenvironment in diagnostic follicular lymphoma (FL) biopsies and evaluate its prognostic significance. Patients and Methods Immunohistochemistry was used to study numbers and location of cells staining positive for immune cell markers CD4, CD7, CD8, CD25, CD68, forkhead box protein P3 (FOXP3), T-cell intracellular antigen-1, and Granzyme B in tissue microarrays of paraffin-embedded, diagnostic lymph node biopsies taken from 59 FL patients who lived less than 5 years (short-survival group; n = 34) and more than 15 years (long-survival group; n = 25). Results CD4 and FOXP3 expression were significantly different between the two groups. Samples from the long-survival group were more likely than those from the short-survival group to have CD4(+) staining cells and to have FOXP3-positive cells in a perifollicular location. Conclusion This study has identified differences in immune cell composition of the diagnostic FL lymph node immune microenvironment and these have the potential for use as prognostic biomarkers in a routine histopathology setting.
引用
收藏
页码:5052 / 5059
页数:8
相关论文
共 32 条
[1]   Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells [J].
Alvaro, T ;
Lejeune, M ;
Salvadó, MT ;
Bosch, R ;
García, JF ;
Jaén, J ;
Banham, AH ;
Roncador, G ;
Montalbán, C ;
Piris, MA .
CLINICAL CANCER RESEARCH, 2005, 11 (04) :1467-1473
[2]   High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up [J].
Apostolidis, J ;
Gupta, RK ;
Grenzelias, D ;
Johnson, PWM ;
Pappa, VI ;
Summers, KE ;
Salam, A ;
Adams, K ;
Norton, AJ ;
Amess, JAL ;
Matthews, J ;
Bradburn, M ;
Lister, TA ;
Rohatiner, AZS .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :527-536
[3]   Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients [J].
Bastion, Y ;
Sebban, C ;
Berger, F ;
Felman, P ;
Salles, G ;
Dumontet, C ;
Bryon, PA ;
Coiffier, B .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) :1587-1594
[4]   Natural regulatory T cells in infectious disease [J].
Belkaid, Y ;
Rouse, BT .
NATURE IMMUNOLOGY, 2005, 6 (04) :353-360
[5]   TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs [J].
Bisikirska, B ;
Colgan, J ;
Luban, J ;
Bluestone, JA ;
Herold, KC .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2904-2913
[6]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[7]  
CARRERAS J, 2006, BLOOD 0706
[8]   ALTERATIONS IN THE HUMAN IMMUNE-RESPONSE TO THE HEPATITIS-B VACCINE AMONG THE ELDERLY [J].
COOK, JM ;
GUALDE, N ;
HESSEL, L ;
MOUNIER, M ;
MICHEL, JP ;
DENIS, F ;
RATINAUD, MH .
CELLULAR IMMUNOLOGY, 1987, 109 (01) :89-96
[9]  
CULLEN MH, 1979, CANCER, V44, P645, DOI 10.1002/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO
[10]  
2-Y